C-8 (PFOA) contamination from DuPont

C-8, the industrial shorthand for perfluorooctanoic acid (PFOA), became among the most consequential environmental and public health controversies in the history of Delaware and the broader United States chemical industry. The DuPont company, long one of Delaware's most prominent corporate institutions and a defining force in the state's economy and identity, used PFOA as a processing aid in the manufacture of Teflon and other fluoropolymer products for decades. The contamination of water supplies, the suppression of internal safety data, and the resulting litigation placed Delaware at the center of a national reckoning over chemical industry accountability, corporate transparency, and the regulation of so-called "forever chemicals."

History

PFOA, or C-8, is a synthetic chemical belonging to the broader family of per- and polyfluoroalkyl substances, commonly referred to as PFAS. These compounds are characterized by extraordinarily stable carbon-fluorine bonds, which make them resistant to heat, water, and chemical degradation. DuPont began using C-8 as a surfactant in its production of Teflon at its Washington Works plant in Parkersburg, West Virginia, beginning in the early 1950s. The chemical allowed fluoropolymer particles to remain suspended in water during the manufacturing process. DuPont sourced C-8 from the 3M company for much of this period, before eventually manufacturing it in-house.

Internal DuPont documents, which later became central to major litigation, indicated that the company had accumulated evidence of C-8's potential health effects over several decades. Studies conducted within the company's own laboratories raised concerns about links between PFOA exposure and serious health conditions, including kidney cancer, testicular cancer, thyroid disease, and other ailments. Despite this, DuPont did not voluntarily disclose its internal findings to regulators or the public for many years. The timeline of what the company knew, and when it knew it, became a significant legal and ethical focal point as litigation expanded into the 2000s and 2010s. Delaware, as the state of DuPont's incorporation and corporate headquarters, was drawn into these questions not only as a legal jurisdiction but as a community with deep cultural and economic ties to the company.

Geography

While the most heavily documented cases of C-8 water contamination centered on communities near DuPont's manufacturing facilities in West Virginia and Ohio, the contamination issue carried significant implications for Delaware because of the state's unique relationship with the company. Wilmington, Delaware, served as DuPont's global headquarters for most of its history, and the state's geography, economy, and civic culture were intertwined with DuPont's corporate presence in ways that made the PFOA controversy particularly resonant locally.

Delaware's geography also made it susceptible to PFAS contamination from multiple industrial and military sources. The state's relatively flat terrain, its position within the Delaware River watershed, and its high concentration of both military installations and legacy industrial sites created conditions where groundwater and surface water contamination could spread. Various sites across Delaware were identified by state environmental authorities as areas of PFAS concern, adding a local dimension to what had initially seemed like a problem confined to DuPont's manufacturing communities elsewhere. The Delaware Department of Natural Resources and Environmental Control (DNREC) began issuing guidance and undertaking investigation of PFAS-related contamination in water supplies across the state.^[1]

Economy

DuPont's relationship with Delaware's economy was transformative and long-standing. Founded in 1802 as a gunpowder manufacturer on the Brandywine Creek near Wilmington, DuPont grew over two centuries into one of the world's largest chemical companies. At its peak, the company employed tens of thousands of Delaware residents and contributed enormously to the state's tax base, philanthropic landscape, and research institutions. The development and commercialization of products like nylon, Kevlar, and Teflon made DuPont a global brand synonymous with American industrial innovation.

The PFOA controversy introduced significant economic uncertainty into this legacy. As litigation mounted and regulatory scrutiny intensified, DuPont undertook a major corporate restructuring. In 2015, DuPont spun off its performance chemicals division into a separate company called Chemours, which assumed responsibility for many of DuPont's legacy environmental liabilities, including those related to PFOA. This restructuring raised substantial concerns among environmental advocates and plaintiffs' attorneys about whether the separation was designed in part to shield DuPont from the full financial consequences of contamination-related claims. The economic ramifications for Delaware extended beyond the company itself: the reputational and financial pressures on DuPont affected employment, real estate values near affected sites, and the broader perception of the state's regulatory environment. News coverage of the issue in local media kept Delaware residents informed of developments as they unfolded.^[2]

Regulatory and Legal History

The legal history of C-8 contamination is among the most complex in American environmental law. Litigation involving DuPont and PFOA contamination near the Washington Works plant in West Virginia produced a landmark class action settlement in the early 2000s, through which DuPont agreed to fund an independent science panel to evaluate potential links between C-8 exposure and human disease. That panel, known as the C8 Science Panel, eventually concluded that there was a "probable link" between PFOA exposure and six diseases: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension. These findings opened the door to thousands of individual personal injury lawsuits against DuPont.

In Delaware, regulatory response developed through multiple channels. The United States Environmental Protection Agency (EPA) had long classified PFOA as an "emerging contaminant" and had undertaken a voluntary stewardship program with major manufacturers to phase out production and use of C-8 by 2015. When that voluntary approach proved insufficient to address the scale of contamination already present in the environment, pressure mounted for enforceable federal standards. Delaware state authorities worked alongside federal regulators to assess PFAS levels in drinking water systems and to communicate risks to the public. The state's Division of Public Health issued advisories and worked with utilities to address contamination where it was found.^[3] Delaware legislators and officials also engaged with federal discussions about establishing legally enforceable maximum contaminant levels for PFAS compounds in drinking water.

The Chemours spinoff became a subject of litigation in its own right. Multiple parties, including state attorneys general and private plaintiffs, argued that the corporate separation was structured to evade liability. Courts in Delaware, given its status as the legal home of both DuPont and Chemours as corporations incorporated under Delaware law, played a role in adjudicating questions related to these corporate governance disputes.

Public Health and Community Impact

The public health implications of C-8 contamination extended far beyond the communities immediately surrounding DuPont's manufacturing plants. Because PFOA was released into the air and water over decades, and because the chemical is extraordinarily persistent, it spread widely through environmental pathways. PFOA has been detected in the blood of individuals with no known direct exposure to DuPont's facilities, reflecting the chemical's prevalence in the broader environment.

For Delaware communities, the public health dimensions of the issue were addressed through a combination of state monitoring, public education, and policy advocacy. Local reporting by Delaware Online and The News Journal provided ongoing coverage of contamination sites, regulatory actions, and the status of litigation, ensuring that residents had access to information about risks in their communities.^[4] Community organizations and environmental advocates in Delaware pushed for more aggressive testing of water systems and greater transparency from both state regulators and corporate defendants. The issue highlighted broader questions about environmental justice, as lower-income communities and communities of color in Delaware and nationwide often faced disproportionate exposure to PFAS and other industrial contaminants while having less access to legal and political resources to seek remediation.

Medical research continued to expand the understanding of PFOA's health effects over time. Studies published in peer-reviewed journals linked PFOA exposure to developmental problems in children, immune system disruption, and a range of endocrine-related conditions. These findings reinforced the urgency of regulatory action and gave additional weight to the claims of communities that had been exposed to the chemical through contaminated water.

History

Geography

Economy

Regulatory and Legal History

Public Health and Community Impact

See Also